Kiran Musunuru

Q: What Schools Are Affiliated With Kiran Musunuru

Kiran Musunuru is affiliated with the following schools: Université de Montréal, Wayne State University, Rockefeller University, Lund University, Massachusetts General Hospital, University of Pennsylvania, Harvard University

Kiran Musunuru's AcademicInfluence.com Rankings

Kiran Musunuru

Philosophy

#3764

World Rank

#6027

Historical Rank

#1161

USA Rank

Logic

#7136

World Rank

#8794

Historical Rank

#1035

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Kiran Musunuru Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kiran Musunuru is an American cardiologist who is a Professor of Medicine at the University of Pennsylvania Perelman School of Medicine. He researches the genetics and genomics of cardiovascular and metabolic diseases. Musunuru is a leading expert in the field of gene-editing.

(See a Problem?)

Kiran Musunuru's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids (2010) (3485)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (2012) (2002)
Common variants at 30 loci contribute to polygenic dyslipidemia (2009) (1380)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants (2009) (1100)
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus (2010) (1048)
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease (2011) (894)
Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans (2016) (790)
Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. (2010) (630)
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids (2015) (531)
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma (2011) (526)
A TALEN genome-editing system for generating human stem cell-based disease models. (2013) (518)
Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. (2014) (501)
Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. (2013) (467)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice (2016) (434)
Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. (2014) (415)
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing (2014) (397)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. (2014) (330)
Sequence-Specific RNA Binding by a Nova KH Domain Implications for Paraneoplastic Disease and the Fragile X Syndrome (2000) (326)
Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. (2012) (303)
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. (2017) (278)
Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention (2010) (275)
Two ZBP1 KH domains facilitate β-actin mRNA localization, granule formation, and cytoskeletal attachment (2003) (250)
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates (2021) (247)
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. (2012) (238)
Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
Programming human pluripotent stem cells into white and brown adipocytes (2012) (218)
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. (2012) (209)
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls (2010) (203)
The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. (2000) (156)
Human Germline Genome Editing. (2017) (156)
In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing (2017) (153)
In utero CRISPR-mediated therapeutic editing of metabolic genes (2018) (150)
Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk (2009) (150)
Candidate Gene Association Resource (CARe): Design, Methods, and Proof of Concept (2010) (143)
Clinical efficacy and safety of statins in managing cardiovascular risk (2008) (141)
Genome editing of human pluripotent stem cells to generate human cellular disease models (2013) (138)
The use of high-sensitivity assays for C-reactive protein in clinical practice (2008) (135)
A Mouse Model of the Human Fragile X Syndrome I304N Mutation (2009) (132)
Genetics of Common, Complex Coronary Artery Disease (2019) (128)
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis. (2016) (127)
Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition (2018) (121)
Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. (2017) (121)
Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. (2018) (118)
Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. (2020) (118)
Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. (2008) (116)
Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. (1999) (113)
Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. (2001) (113)
Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. (2017) (112)
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins (2022) (109)
The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. (2009) (105)
Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3. (2018) (93)
CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo—Brief Report (2016) (92)
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (2010) (89)
Myocardial Infarction–Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries (2015) (80)
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. (2010) (80)
Association of Single Nucleotide Polymorphisms on Chromosome 9p21.3 With Platelet Reactivity: A Potential Mechanism for Increased Vascular Disease (2010) (78)
Cell-specific RNA-binding proteins in human disease. (2003) (77)
Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells. (2016) (77)
Genome editing in cardiovascular diseases (2017) (77)
Stem cell models of cardiac development and disease. (2010) (76)
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis. (2016) (71)
Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. (2018) (69)
In utero gene editing for monogenic lung disease (2019) (67)
Clinical and research applications of carotid intima-media thickness. (2009) (64)
Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. (2011) (59)
Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association (2016) (54)
Genetics of coronary artery disease. (2010) (53)
Gene-Centric Meta-Analysis of Lipid Traits in African, East Asian and Hispanic Populations (2012) (51)
Defining the spectrum of alleles that contribute to blood lipid concentrations in humans (2008) (49)
Multi-Ethnic Analysis of Lipid-Associated Loci: The NHLBI CARe Project (2012) (47)
A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation (2020) (46)
Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells (2016) (44)
Tunable and Reversible Substrate Stiffness Reveals a Dynamic Mechanosensitivity of Cardiomyocytes. (2019) (44)
The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review (2017) (42)
Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. (2015) (41)
ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development. (2017) (40)
Future Translational Applications From the Contemporary Genomics Era: A Scientific Statement From the American Heart Association (2015) (39)
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes. (2021) (38)
NLRP2 is a suppressor of NF-B signaling and HLA-C expression in human trophoblasts (2017) (37)
Transcriptome-Wide Analysis Reveals Modulation of Human Macrophage Inflammatory Phenotype Through Alternative Splicing (2016) (36)
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association (2020) (36)
Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies (2015) (36)
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. (2012) (34)
Investigation of a dilated cardiomyopathy-associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes. (2019) (34)
Genome-Edited Human Pluripotent Stem Cell–Derived Macrophages as a Model of Reverse Cholesterol Transport—Brief Report (2016) (33)
The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction A Scientific Statement From the American Heart Association (2017) (32)
Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes. (2018) (29)
Determination and augmentation of RNA sequence specificity of the Nova K-homology domains. (2004) (27)
Confirmation of Causal rs9349379-PHACTR1 Expression Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial Cells (2018) (27)
Interrogation of the Atherosclerosis-Associated SORT1 (Sortilin 1) Locus With Primary Human Hepatocytes, Induced Pluripotent Stem Cell-Hepatocytes, and Locus-Humanized Mice (2018) (26)
Genome engineering tools for building cellular models of disease (2016) (25)
Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells (2018) (25)
Biomarkers for prediction of cardiovascular events. (2007) (24)
Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors (2022) (24)
Genome Editing: The Recent History and Perspective in Cardiovascular Diseases. (2017) (24)
Modulators of Hepatic Lipoprotein Metabolism Identified in a Search for Small-Molecule Inducers of Tribbles Pseudokinase 1 Expression (2015) (24)
Genome editing in human pluripotent stem cells (2014) (23)
Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial. (2019) (23)
Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma (2008) (23)
Genome Editing for the Study of Cardiovascular Diseases (2017) (22)
Functional Assays to Screen and Dissect Genomic Hits: Doubling Down on the National Investment in Genomic Research. (2018) (21)
Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group (2012) (21)
In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease (2021) (21)
The clinical application of gene editing: ethical and social issues. (2019) (20)
Angiopoietin-Like 3 (2019) (19)
HapMap and Mapping Genes for Cardiovascular Disease (2008) (18)
Association of common DNA sequence variants at 33 genetic loci with blood lipids in individuals of African ancestry from Jamaica (2010) (17)
Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR / Cas 9 Graphical (2014) (17)
Supplemental Information Protein-RNA and Protein-Protein Recognition by Dual KH 1 / 2 Domains of the Neuronal Splicing Factor Nova-1 (2011) (16)
Cardiovascular endocrinology: Is ANGPTL3 the next PCSK9? (2017) (16)
Active learning-based STEM education for in-person and online learning (2021) (16)
Mapping Novel Pathways in Cardiovascular Disease Using eQTL Data: The Past, Present, and Future of Gene Expression Analysis (2013) (16)
CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia. (2018) (16)
Low Incidence of Off-Target Mutations in Individual CRISPR-Cas 9 and TALEN Targeted Human Stem Cell Clones Detected (2015) (14)
Moving toward genome-editing therapies for cardiovascular diseases (2022) (14)
What do we do now?: Responding to claims of germline gene editing in humans (2019) (14)
Insulin-stimulated phosphatidylcholine hydrolysis, diacylglycerol/protein kinase C signalling, and hexose transport in pertussis toxin-treated BC3H-1 myocytes. (1994) (14)
Widespread central nervous system cavernous malformations associated with café-au-lait skin lesions. Case report. (2003) (13)
Preferential activation of microsomal diacylglycerol/protein kinase C signaling during glucose treatment (De Novo phospholipid synthesis) of rat adipocytes. (1994) (13)
Functional evaluation of genetic variation in complex human traits. (2012) (13)
Medical Misinformation. (2019) (12)
Rapid generation of novel models of RAG1 deficiency by CRISPR/Cas9-induced mutagenesis in murine zygotes (2016) (12)
Long-term management of bilateral metastases of renal cell carcinoma to the choroid plexus (2003) (12)
From Genotype to Phenotype: A Primer on the Functional Follow-Up of Genome-Wide Association Studies in Cardiovascular Disease (2018) (12)
Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing. (2020) (11)
What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine? (2017) (11)
Treatment of an anterior communicating artery aneurysm through an anomalous anastomosis from the cavernous internal carotid artery. (2002) (11)
Candidate Gene Association Resource (CARe)Clinical Perspective (2010) (10)
ANGPTL 3 De fi ciency and Protection Against Coronary Artery Disease (2017) (10)
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing (2017) (10)
Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals. (2021) (10)
How genome editing could be used in the treatment of cardiovascular diseases. (2018) (10)
Cell cycle regulators in cancer (1997) (10)
Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 Inhibition. (2020) (10)
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis. (2017) (10)
Cardioprotective Effects of MTSS1 Enhancer Variants. (2019) (9)
From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies (2019) (9)
Turning up the Heat with Therapeutic Epigenome Editing. (2018) (9)
Medical Misinformation: Vet the Message! (2019) (8)
Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects (2021) (8)
Enduring mystery of the chromosome 9p21.3 locus. (2013) (8)
Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association. (2018) (7)
Personalized genomes and cardiovascular disease. (2014) (7)
High-Throughput Screening and CRISPR-Cas9 Modeling of Causal Lipid-Associated Expression Quantitative Trait Locus Variants (2016) (7)
Improving Genomic Literacy Among Cardiovascular Practitioners via a Flipped-Classroom Workshop at a National Meeting. (2016) (7)
Author Correction: Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition (2018) (6)
(Pro)renin Receptor and LDL Clearance: An Old Player Joins A New Game. (2016) (6)
Self‐Organizing Human Induced Pluripotent Stem Cell Hepatocyte 3D Organoids Inform the Biology of the Pleiotropic TRIB1 Gene (2020) (6)
Natriuretic Peptide Deficiency in Obese Individuals: Mechanistic Insights From Healthy Organ Donor Cohort. (2021) (6)
CHAPTER 13 – Use of High-Sensitivity C-Reactive Protein for Risk Assessment (2009) (5)
Regulatory elements in noncoding DNA in the chromosome 9p21 locus. (2011) (5)
Therapeutic application of genome editing in dyslipidemia (2021) (4)
EDEM3 Modulates Plasma Triglyceride Level through Its Regulation of LRP1 Expression (2019) (4)
A synergistic relationship of elevated low-density lipoprotein cholesterol levels and systolic blood pressure with coronary artery calcification. (2008) (4)
Medical Misinformation: Vet the Message! (2019) (4)
Lipid nanoparticles incorporating a GalNAc ligand enable in vivo liver ANGPTL3 editing in wild-type and somatic LDLR knockout non-human primates (2021) (4)
Translating Research into Therapies (2012) (4)
Lack of association of KIF6 genotype with vascular disease and statin response. (2011) (4)
CRISPR and Cardiovascular Diseases. (2022) (4)
The Implications of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression Trial: A Return to First Principles (2008) (4)
RNA-binding protein A1CF modulates plasma triglyceride levels through posttranscriptional regulation of stress-induced VLDL secretion (2018) (4)
Novel tricyclic glycal-based TRIB1 inducers that reprogram LDL metabolism in hepatic cells. (2018) (3)
Genetics and Genomics of Atherosclerotic Cardiovascular Disease (2020) (3)
Adipocyte-specific modulation of KLF14 expression in mice leads to sex-dependent impacts in adiposity and lipid metabolism (2021) (3)
Challenges and advances of CRISPR-Cas9 genome editing in therapeutics (2019) (3)
Medical Misinformation: Vet the Message! (2019) (2)
Top advances in functional genomics and translational biology for 2011. (2012) (2)
CRISPR Hits Home in a First-in-Human Study. (2021) (2)
Therapeutic genome editing (2021) (2)
Medical misinformation: vet the message! (2019) (2)
Why Human Embryo Editing Should Be Banned. (2019) (2)
Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoproteins (2018) (2)
Abstract 70: KLF14 is a Novel Regulator of Human Metabolism (2014) (2)
Evaluating the contribution of cell-type specific alternative splicing to variation in lipid levels (2019) (2)
BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors (2022) (1)
Transforming growth factor β2 mutations and familial thoracic aortic aneurysms. (2012) (1)
Medical misinformation: Vet the message! (2019) (1)
Current Role of Pharmacogenomics in Cardiovascular Medicine (2011) (1)
Randomized controlled studies comparing traditional lectures versus online modules (2021) (1)
ANGPTL3 De ﬁ ciency and Protection Against Coronary Artery Disease (1)
Medical Misinformation. (2019) (1)
Induction of cardiomyocytes from cardiac fibroblasts. (2012) (1)
Base editing (2021) (1)
Reply: Loss-of-Function Mutations to Estimate Pharmacological ANGPTL3 Inhibition. (2017) (1)
Base editing: a brief review and a practical example (2020) (1)
In This Issue: March. (2018) (1)
Stem cell modeling of lipid genetics (2018) (1)
Choosing a nuclease, guide RNA, and repair template (2021) (0)
Medical Misinformation. (2019) (0)
CRYSTAL STRUCTURE OF NOVA-2 KH3 K-HOMOLOGY RNA-BINDING DOMAIN BOUND TO 20-MER RNA HAIRPIN (2000) (0)
In utero CRISPR-mediated therapeutic editing of metabolic genes (2018) (0)
Abstract 498: Functional Annotation of TNNT2 Variants of Uncertain Significance With Induced Pluripotent Stem Cell-derived Cardiomyocytes (2018) (0)
Genome editing for functional experiments and screens (2021) (0)
Reprogramming of hepatic lipoprotein metabolism by small molecule inducers of TRIB1 expression (998.1) (2014) (0)
Abstract 240: Predictive and Experimental Modeling of Bag3-associated Cardiomyocyte Dysfunction (2018) (0)
Top advances in functional genomics and translational biology for 2012. (2013) (0)
Detoxifying chemotherapy with genetics-guided stem cell modeling: A personalized affair. (2021) (0)
Safety, Health and Environment (2014) (0)
Short title: Musunuru et al; Design of NHLBI CARe (2017) (0)
Correcting tyrosinaemia via a point mutation (2020) (0)
Abstract 18960: RNA-binding Protein A1CF Modulates Plasma Triglyceride Levels Through Transcriptomic Regulation of Stress-Induced VLDL Secretion (2017) (0)
Medical Misinformation. (2019) (0)
Abstract 97: Genotype to Phenotype: Function of Common Noncoding and Rare Coding Variants In ANGPTL3 (2017) (0)
Abstract 013: Genotype to Phenotype: Function of Rare Coding Variants in ANGPTL3 (2018) (0)
CRYSTAL STRUCTURE OF NOVA-2 KH3 K-HOMOLOGY RNA-BINDING DOMAIN (2000) (0)
Adenine base editing to treat progeria syndrome and extend the lifespan (2021) (0)
List of Contributors (2020) (0)
Crystal structure (I) of Nova-1 KH1/KH2 domain tandem with 25 nt RNA hairpin (2006) (0)
Abstract 157: Alternative Splicing of PLD1 and Its Role in Modulating Inflammatory Phenotypes in Primary Human Macrophages (2016) (0)
481. CRISPR/Cas9-Mediated In Vivo Genome Editing to Correct the OTC spfash Mutation in Newborn Mice (2016) (0)
Leveraging CRISPR/Cas Genome Editing Technology to Identify and Characterize Causal GWAS Variants for Blood Lipids (2018) (0)
Alternative types of editing (2021) (0)
Protein-6 and Coronary Artery Disease in 19 Case-Control Studies Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like (2012) (0)
Methods in Genetics and Clinical Interpretation HapMap and Mapping Genes for Cardiovascular Disease (2008) (0)
Medical Misinformation: Vet the Message! (2019) (0)
Abstract 15407: Humanity in a Dish: Investigating a Common Genetic Basis for Human Metabolic Disease With Induced Pluripotent Stem Cells (2016) (0)
Kiran Musunuru Induction of Cardiomyocytes From Cardiac Fibroblasts (2012) (0)
What do we do now?: Responding to claims of germline gene editing in humans (2019) (0)
CRISPR/Cas9 screens implicate RARA and SPNS1 in doxorubicin cardiotoxicity (2022) (0)
SORTI: deciphering the biological and genetic link between cholesterol and coronary heart disease (2010) (0)
Identification of a growth factor that rejuvenates the heart. (2013) (0)
Assessing for off-target mutagenesis (2021) (0)
Correcting tyrosinaemia via a point mutation (2020) (0)
Medical Misinformation. (2019) (0)
High-throughput Screening and CRISPR-Cas 9 Modeling of Causal Lipid-associated 1 Expression Quantitative Trait Locus Variants 2 3 (2016) (0)
A brief history and primer on genome editing (2021) (0)
Choosing a genome editing strategy and target site (2021) (0)
Assessing the outcomes of genome editing (2021) (0)
Exome sequencing to identify novel genes in hypertension. (2012) (0)
on a National Heart, Lung and Blood Institute Working Group Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report (2014) (0)
Past Successes of Genetic Findings Familial Hypercholesterolemia and Low-Density Lipoprotein Cholesterol Lowering (2015) (0)
The Stroke Genetics Network: living up to its potential. (2013) (0)
Cardiovascular Genetics : A News Round-Up Omics Gets Personal Integrative Profiling of Health and Disease (2012) (0)
Medical misinformation: vet the message! (2019) (0)
Efficient prime editing in mouse brain, liver and heart with dual AAVs. (2023) (0)
Medical Misinformation. (2019) (0)
Publisher Correction: Efficient in vivo base editing via single adenoassociated viruses with size-optimized genomes encoding compact adenine base editors (2022) (0)
Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition (2018) (0)
Genome editing for cellular disease modeling (2021) (0)
Abstract 11154: Cardioprotective Effects of Mtss1 Reduction Iin Dilated Cardiomyopathy (2021) (0)
Abstract 27: Therapeutic Targeting of Human Lipid Genes With in vivo CRISPR-Cas9 Genome Editing (2015) (0)
Abstract 55: Disruption of PCSK9 Using a Targeted Base Editing Strategy (2017) (0)
Do Evidence-Based Clinical Guidelines Do More Harm Than Good? (2011) (0)
Leading Edge Review GeneticsofCommon , ComplexCoronaryArteryDisease (2019) (0)
Cardiomyopathy During A Partial Molar Pregnancy (2022) (0)
Abstract # 10083: From Genotype to Phenotype at a Novel Cholesterol and Myocardial Infarction Locus (2010) (0)
Medical Misinformation - Vet the Message! (2019) (0)
Figure 3, Generic TALEN amino acid sequences (to recognize 15 bp DNA sequences). (2013) (0)
An Overview of Genome Editing in Cardiovascular and Metabolic Diseases. (2023) (0)
Abstract 5: Sortilin Regulates Hepatic VLDL Secretion and LDL Uptake in a Lysosome-Dependent Manner (2012) (0)
Abstract 125: Reversible Epigenome Editing Of PCSK9 As A Therapeutic Strategy (2022) (0)
Scientists on the Spot: The future of genome editing in cardiovascular medicine (2019) (0)
Supplementary Material (nature09270-s1) (2012) (0)
Medical Misinformation. (2019) (0)
ION Mobility Analysis Of Lipoprotein Subfractions Suggests Three Independent Mechanisms Of Cardiovascular Risk (2009) (0)
A TALEN genome editing system to generate human stem cell-based disease models (2013) (0)
Novel Genes for Dyslipidemias: Genome-Wide Association Studies (2015) (0)
Figure 1, Overview of hPSC TALEN genome editing process. (2013) (0)
Ongoing Promises and Public Expectations of the HGP (0)
Deciphering Cardiovascular Genomics and How They Apply to Cardiovascular Disease Prevention (2018) (0)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Myocardial Infarction Genetics Consortium * (2009) (0)
Genome editing of a CArG element in the mouse genome establishes its role in gene expression. (2015) (0)
Figure 2, Example genome editing target site showing TALEN design criteria. (2013) (0)
Abstract 1438: Myocardial Infarction Associated SNPs on Chromosome 9p21.3 are Associated with Coronary Artery Calcification but Not Carotid Intimal Medial Thickness in the Amish (2008) (0)
Abstract 21: Sortilin Is a Novel Mediator of Cellular Low-Density Lipoprotein Uptake (2012) (0)
Author Correction: Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition (2018) (0)
ASHG POSITION STATEMENT Human Germline Genome Editing (2017) (0)
Abstract 18593: Use of a CRISPR/Cas System for Cardiovascular Disease Modeling and Therapeutic Applications (2013) (0)
Figure 4, Representative FACS plots illustrating isolation of TALEN expressing hESCs. (2013) (0)
Abstract 242: Functional Characterization of a Cis-eQTL Locus for Plasma Cholesterol Using CRISPR/Cas Genome Editing in Human Pluripotent Stem Cells (2014) (0)
Abstract 17325: Obesity, Blood Pressure, and Diurnal Variation in Natriuretic Peptides: A Clinical Trial (2020) (0)
Genetics of Cardiovascular Disease and Its Role in Risk Prediction (2011) (0)
Medical misinformation: vet the message! (2019) (0)
The use of ZFNs , TALENs , and CRISPR-Cas 9 for precision genome editing in mammals (2015) (0)
In This Issue: April. (2018) (0)
Abstract 214: Functional Analysis of the Low Density Lipoprotein Receptor Using Saturation Mutagenesis Strategies (2018) (0)
Figure 5, Representative images showing the expansion and screening of hESC lines during the genome editing process. (2013) (0)

This paper list is powered by the following services:

Other Resources About Kiran Musunuru

en.wikipedia.org

What Schools Are Affiliated With Kiran Musunuru?

Kiran Musunuru is affiliated with the following schools: